Jurkat T Cells are Immunophenotypically Distinct from T-Cell Acute Lymphoblastic Leukemia Cells Due to High-Level Surface Expression of CD5

Cancer Invest. 2022 Sep;40(8):675-679. doi: 10.1080/07357907.2022.2095397. Epub 2022 Jul 5.

Abstract

Human leukemic T cells show decreased surface CD5 (sCD5) and increased cytoplasmic CD5 (cCD5). When we examined their expressions in the Jurkat T cells, it showed increased sCD5 and decreased cCD5, which is in sharp contrast with the pattern of CD5 expression observed for human leukemic T cells. Furthermore, this opposite pattern was due to the absence of an exonal switch between E1A and E1B. This study suggests that Jurkat cell does not retain all characteristics of T-ALL cells; thus, we should carefully interpret the data obtained using Jurkat T cell as a model cell line of T-ALL.

Keywords: Acute T cell lymphoblastic leukemia; Jurkat T cell; cytoplasmic CD5 (cCD5); surface CD5 (sCD5).

MeSH terms

  • Cell Line
  • Humans
  • Jurkat Cells
  • Leukemia-Lymphoma, Adult T-Cell*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*